Cargando…

Notch2 controls hepatocyte-derived cholangiocarcinoma formation in mice

Liver cancer comprises a group of malignant tumors, among which hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC) are the most common. ICC is especially pernicious and associated with poor clinical outcome. Studies have shown that a subset of human ICCs may originate from matu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Jingxiao, Dong, Mingjie, Xu, Zhong, Song, Xinhua, Zhang, Shanshan, Qiao, Yu, Che, Li, Gordan, John, Hu, Kaiwen, Liu, Yan, Calvisi, Diego F., Chen, Xin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6002343/ https://www.ncbi.nlm.nih.gov/pubmed/29545603 http://dx.doi.org/10.1038/s41388-018-0188-1

Ejemplares similares

Crenigacestat, a selective NOTCH1 inhibitor, reduces intrahepatic cholangiocarcinoma progression by blocking VEGFA/DLL4/MMP13 axis
por: Mancarella, Serena, et al.
Publicado: (2020)

Efficacy of MEK inhibition in a K-Ras-driven cholangiocarcinoma preclinical model
por: Dong, Mingjie, et al.
Publicado: (2018)

Jagged 1 is a major Notch ligand along cholangiocarcinoma development in mice and humans
por: Che, L, et al.
Publicado: (2016)

The Hippo pathway effector TAZ induces intrahepatic cholangiocarcinoma in mice and is ubiquitously activated in the human disease
por: Cigliano, Antonio, et al.
Publicado: (2022)

Correction: The Hippo pathway efector TAZ induces intrahepatic cholangiocarcinoma in mice and is ubiquitously activated in the human disease
por: Cigliano, Antonio, et al.
Publicado: (2023)

MEK inhibition suppresses K-Ras wild-type cholangiocarcinoma in vitro and in vivo via inhibiting cell proliferation and modulating tumor microenvironment
por: Wang, Pan, et al.
Publicado: (2019)

CD90 is regulated by notch1 and hallmarks a more aggressive intrahepatic cholangiocarcinoma phenotype
por: Mancarella, Serena, et al.
Publicado: (2022)

Correction: CD90 is regulated by notch1 and hallmarks a more aggressive intrahepatic cholangiocarcinoma phenotype
por: Mancarella, Serena, et al.
Publicado: (2023)

Kupffer cells induce Notch-mediated hepatocyte conversion in a common mouse model of intrahepatic cholangiocarcinoma
por: Terada, Maiko, et al.
Publicado: (2016)

Crenigacestat blocking notch pathway reduces liver fibrosis in the surrounding ecosystem of intrahepatic CCA viaTGF-β inhibition
por: Mancarella, Serena, et al.
Publicado: (2022)

Nuclear ErbB2 expression in hepatocytes in liver disease
por: Döring, Paula, et al.
Publicado: (2020)

A new mission for an old anti-cancer drug: harnessing hepatocyte-specific metabolic pathways against liver tumors
por: Liao, Weiting, et al.
Publicado: (2023)

Notch signalling pathway in development of cholangiocarcinoma
por: Rauff, Bisma, et al.
Publicado: (2020)

Oncogene-dependent function of BRG1 in hepatocarcinogenesis
por: Wang, Pan, et al.
Publicado: (2020)

Distinct and Overlapping Roles of Hippo Effectors YAP and TAZ During Human and Mouse Hepatocarcinogenesis
por: Wang, Haichuan, et al.
Publicado: (2020)

Functional role of SGK3 in PI3K/Pten driven liver tumor development
por: Cao, Hui, et al.
Publicado: (2019)

Fascin1 empowers YAP mechanotransduction and promotes cholangiocarcinoma development
por: Pocaterra, Arianna, et al.
Publicado: (2021)

Combined Treatment with MEK and mTOR Inhibitors is Effective in In Vitro and In Vivo Models of Hepatocellular Carcinoma
por: Liu, Xianqiong, et al.
Publicado: (2019)

Cabozantinib-based combination therapy for the treatment of hepatocellular carcinoma
por: Shang, Runze, et al.
Publicado: (2021)

The roles of Notch1 expression in the migration of intrahepatic cholangiocarcinoma
por: Zhou, Qi, et al.
Publicado: (2013)

Genetic Mouse Models as In Vivo Tools for Cholangiocarcinoma Research
por: Erice, Oihane, et al.
Publicado: (2019)

Hepatitis B virus-related intrahepatic cholangiocarcinoma originates from hepatocytes
por: Song, Zimin, et al.
Publicado: (2023)

Oncogenic potential of N-terminal deletion and S45Y mutant β-catenin in promoting hepatocellular carcinoma development in mice
por: Qiao, Yu, et al.
Publicado: (2018)

Focal adhesion kinase activation limits efficacy of Dasatinib in c‐Myc driven hepatocellular carcinoma
por: Liu, Xianqiong, et al.
Publicado: (2018)

Inhibition of MELK Protooncogene as an Innovative Treatment for Intrahepatic Cholangiocarcinoma
por: Cigliano, Antonio, et al.
Publicado: (2019)

Cholesterol biosynthesis supports the growth of hepatocarcinoma lesions depleted of fatty acid synthase in mice and humans
por: Che, Li, et al.
Publicado: (2020)

Notch signaling in the pathogenesis, progression and identification of potential targets for cholangiocarcinoma (Review)
por: Vanaroj, Peeranate, et al.
Publicado: (2022)

Notch-mediated hepatocyte MCP-1 secretion causes liver fibrosis
por: Kang, Jinku, et al.
Publicado: (2023)

MFAP5 facilitates the aggressiveness of intrahepatic Cholangiocarcinoma by activating the Notch1 signaling pathway
por: Li, Jian-Hui, et al.
Publicado: (2019)

Corilagin suppresses cholangiocarcinoma progression through Notch signaling pathway in vitro and in vivo
por: GU, YUE, et al.
Publicado: (2016)

Induction of differentiation of intrahepatic cholangiocarcinoma cells to functional hepatocytes using an organoid culture system
por: Saito, Yoshimasa, et al.
Publicado: (2018)

High Prevalence of Human Polyomavirus 7 in Cholangiocarcinomas and Adjacent Peritumoral Hepatocytes: Preliminary Findings
por: Klufah, Faisal, et al.
Publicado: (2020)

Activation of Notch Signaling Is Required for Cholangiocarcinoma Progression and Is Enhanced by Inactivation of p53 In Vivo
por: El Khatib, Mona, et al.
Publicado: (2013)

Loss of Numb promotes hepatic progenitor expansion and intrahepatic cholangiocarcinoma by enhancing Notch signaling
por: Shu, Yuke, et al.
Publicado: (2021)

Hepatocyte nuclear factor-1beta enhances the stemness of hepatocellular carcinoma cells through activation of the Notch pathway
por: Zhu, Jing-Ni, et al.
Publicado: (2017)

Cabozantinib for HCC Treatment, From Clinical Back to Experimental Models
por: Deng, Shanshan, et al.
Publicado: (2021)

Novel strategy for hepatocyte transplantation using resected organ with hepatocellular carcinoma or cholangiocarcinoma after hepatectomy
por: Kawai, Toki, et al.
Publicado: (2020)

Autophagy suppresses the formation of hepatocyte-derived cancer-initiating ductular progenitor cells in the liver
por: Barthet, Valentin J. A., et al.
Publicado: (2021)

Patient-Derived Organoids of Cholangiocarcinoma
por: Maier, Christopher Fabian, et al.
Publicado: (2021)

Correction: Activation of Notch Signaling Is Required for Cholangiocarcinoma Progression and Is Enhanced by Inactivation of p53 In Vivo
por: El Khatib, Mona, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_93jrs89ck3oq7s9802si6iurun